103 results on '"Adrianto I"'
Search Results
2. 1604 CyTOF immunoprofiling of whole blood from patients with hidradenitis suppurativa shows sex- and race-specific differences and uncovers cellular biomarkers of biologic response
- Author
-
Young, A.T., primary, Dimitrion, P., additional, Hans, A., additional, Yin, C., additional, Santra, M., additional, Adrianto, I., additional, Hamzavi, I., additional, Zhou, L., additional, and Mi, Q., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Polygenic risk assessment reveals pleiotropy between sarcoidosis and inflammatory disorders in the context of genetic ancestry
- Author
-
Lareau, C A, DeWeese, C F, Adrianto, I, Lessard, C J, Gaffney, P M, Iannuzzi, M C, Rybicki, B A, Levin, A M, and Montgomery, C G
- Published
- 2017
- Full Text
- View/download PDF
4. 542 Murine epidermis harbors functionally distinct langerhans cell subsets
- Author
-
Dimitrion, P., primary, Adrianto, I., additional, Yao, Y., additional, Pawlitz, M., additional, Loveless, I., additional, Peng, H., additional, Zhou, L., additional, and Mi, Q., additional
- Published
- 2022
- Full Text
- View/download PDF
5. LB922 CyTOF immune profiling uncovers sex- and race-specific differences and cellular biomarkers for biologic response in Hidradenitis suppurativa
- Author
-
Wang, P., Dimitrion, P., Young, A., Yin, C., Hamzavi, I., Adrianto, I., Zhou, L., and Mi, Q.
- Published
- 2024
- Full Text
- View/download PDF
6. 387 Environment impacts the phenotypic severity of flaky tail, MC903-induced inflammation, and dysbiosis in filaggrin-null mice
- Author
-
Hicks, A., Bharmal, M., Schmidt, A., Zheng, Q., Yin, C., Dimitrion, P., Mi, Q., Grice, E., Adrianto, I., and de Guzman Strong, C.
- Published
- 2024
- Full Text
- View/download PDF
7. POS0098 LINC01871, IMPLICATED IN SJÖGREN’S DISEASE PATHOGENESIS, IS REGULATED BY INTERFERON-G AND CALCINEURIN SIGNALING
- Author
-
Joachims, M. L., primary, Khatri, B., additional, Li, C., additional, Tessneer, K. L., additional, Ice, J., additional, Stolarczyk, A. M., additional, Means, N., additional, Grundahl, K., additional, Glenn, S., additional, Kelly, J., additional, Lewis, D., additional, Radfar, L., additional, Stone, D., additional, Guthridge, J., additional, James, J. A., additional, Scofield, R. H., additional, Wiley, G. B., additional, Wren, J., additional, Gaffney, P. M., additional, Montgomery, C., additional, Sivils, K., additional, Rasmussen, A., additional, Farris, A. D., additional, Adrianto, I., additional, and Lessard, C., additional
- Published
- 2022
- Full Text
- View/download PDF
8. Tribbles 2 confers enzalutamide resistance in prostate cancer by promoting lineage plasticity
- Author
-
Adrianto I, Jagadananda Ghosh, Amina Zoubeidi, Himisha Beltran, Dhananjay Chitale, Monga J, Carl R. Rogers, Joshi J. Alumkal, and Gadgeel S
- Subjects
Lineage (genetic) ,business.industry ,Disease ,medicine.disease ,Neuroendocrine differentiation ,Androgen receptor ,Prostate cancer ,chemistry.chemical_compound ,chemistry ,SOX2 ,Cancer research ,medicine ,Enzalutamide ,business ,Transcription factor - Abstract
Second-generation anti-androgen, such as enzalutamide (Xtandi), is commonly prescribed for prostate cancer therapy, but enzalutamide-resistant, lethally incurable disease invariably develops. To understand the molecular basis of enzalutamide resistance, we comprehensively analyzed prostate tumors and clinically relevant models. These studies revealed that enzalutamide resistant prostate cancer cells overexpress Tribbles 2 (Trib2), a pseudokinase. Expression of Trib2 is negatively regulated by androgen receptor signaling. Overexpression of Trib2 makes prostate cancer cells completely resistant to clinically relevant doses of enzalutamide. Trib2 downregulates expression of luminal markers but upregulates the neuronal transcription factor, BRN2, and the stemness factor, SOX2, to induce neuroendocrine differentiation. Our findings indicate that Trib2 confers resistance to enzalutamide therapy via a mechanism involving increased cellular plasticity and lineage switching.
- Published
- 2021
9. A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus
- Author
-
Wang, S, Adrianto, I, Wiley, G B, Lessard, C J, Kelly, J A, Adler, A J, Glenn, S B, Williams, A H, Ziegler, J T, Comeau, M E, Marion, M C, Wakeland, B E, Liang, C, Kaufman, K M, Guthridge, J M, Alarcón-Riquelme, M E, Alarcón, G S, Anaya, J-M, Bae, S-C, Kim, J-H, Joo, Y B, Boackle, S A, Brown, E E, Petri, M A, Ramsey-Goldman, R, Reveille, J D, Vilá, L M, Criswell, L A, Edberg, J C, Freedman, B I, Gilkeson, G S, Jacob, C O, James, J A, Kamen, D L, Kimberly, R P, Martin, J, Merrill, J T, Niewold, T B, Pons-Estel, B A, Scofield, R H, Stevens, A M, Tsao, B P, Vyse, T J, Langefeld, C D, Harley, J B, Wakeland, E K, Moser, K L, Montgomery, C G, and Gaffney, P M
- Published
- 2012
- Full Text
- View/download PDF
10. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis
- Author
-
Lin, C P, Adrianto, I, Lessard, C J, Kelly, J A, Kaufman, K M, Guthridge, J M, Freedman, B I, Anaya, J-M, Alarcón-Riquelme, M E, Pons-Estel, B A, Martin, J, Glenn, S, Adler, A, Bae, S-C, Park, S-Y, Bang, S-Y, Song, Y-W, Boackle, S A, Brown, E E, Edberg, J C, Alarcón, G S, Petri, M A, Criswell, L A, Ramsey-Goldman, R, Reveille, J D, Vila, L M, Gilkeson, G S, Kamen, D L, Ziegler, J, Jacob, C O, Rasmussen, A, James, J A, Kimberly, R P, Merrill, J T, Niewold, T B, Scofield, R H, Stevens, A M, Tsao, B P, Vyse, T J, Langefeld, C D, Moser, K L, Harley, J B, Gaffney, P M, and Montgomery, C G
- Published
- 2012
- Full Text
- View/download PDF
11. OP0140 DYSREGULATED EXPRESSION OF THE LONG NON-CODING RNA, LINC01871, IMPLICATED IN SJÖGREN’S SYNDROME PATHOGENESIS
- Author
-
Joachims, M. L., primary, Khatri, B., additional, Tessneer, K. L., additional, Stolarczyk, A. M., additional, Wiley, G. B., additional, Rasmussen, A., additional, Guthridge, J., additional, James, J. A., additional, Scofield, R. H., additional, Sivils, K. L., additional, Adrianto, I., additional, and Lessard, C., additional
- Published
- 2020
- Full Text
- View/download PDF
12. Functional characterization of the sjögren’s syndrome-associated locus DDX6-CXCR5
- Author
-
Khanam, S., Joachims, M. L., Means, N., Omdal, R., Wahren-Herlenius, M., Alevizos, I., Witte, T., Jonsson, R., Rischmueller, M., Rhodus, N. L., Montgomery, C., Ng, W. -F, Nordmark, Gunnel, Adrianto, I., Sivils, K., Lessard, C., Khanam, S., Joachims, M. L., Means, N., Omdal, R., Wahren-Herlenius, M., Alevizos, I., Witte, T., Jonsson, R., Rischmueller, M., Rhodus, N. L., Montgomery, C., Ng, W. -F, Nordmark, Gunnel, Adrianto, I., Sivils, K., and Lessard, C.
- Published
- 2018
- Full Text
- View/download PDF
13. AB0153 Functional characterization of the sjögren’s syndrome-associated locus ddx6-cxcr5
- Author
-
Khanam, S., primary, Joachims, M.L., additional, Means, N., additional, Omdal, R., additional, Wahren-Herlenius, M., additional, Alevizos, I., additional, Witte, T., additional, Jonsson, R., additional, Rischmueller, M., additional, Rhodus, N.L., additional, Montgomery, C., additional, Ng, W.-F., additional, Nordmark, G., additional, Adrianto, I., additional, Sivils, K., additional, and Lessard, C., additional
- Published
- 2018
- Full Text
- View/download PDF
14. FRI0270 Identification of novel dysregulated interferon-inducible non-coding rnas in sjÖgren’s syndrome
- Author
-
Means, N., primary, Ice, J.A., additional, Adrianto, I., additional, Stolarczyk, A.M., additional, Joachims, M.L., additional, Rasmussen, A., additional, Guthridge, J.M., additional, James, J.A., additional, Scofield, R.H., additional, Sivils, K.L., additional, and Lessard, C.J., additional
- Published
- 2018
- Full Text
- View/download PDF
15. AB0143 Immunomodulation followed by quantitative transcriptional profiling to characterize the functional role of the sjÖgren's-associated ncrna ac092580.4
- Author
-
Ice, JA, primary, Adrianto, I, additional, Rasmussen, A, additional, Joachims, M, additional, Johnston, A, additional, Montgomery, C, additional, Sivils, K, additional, and Lessard, CJ, additional
- Published
- 2017
- Full Text
- View/download PDF
16. Identification of Sjögren's Syndrome Risk Loci near TNFAIP3 and PRDM1
- Author
-
Lessard, C., Li, H., Ice, J. A., Adrianto, I., Rasmussen, A., Lewis, D. M., Radfar, L., Stone, D. U., Montgomery, C. G., Rhodus, N. L., Scofield, R. H., Farris, A. D., Omdal, R., Wahren-Herlenius, M., Alevizos, I., Witte, T., Jonsson, R., Rischmueller, M., Rönnblom, Lars, Mariette, X., Ng, W. -F, Nordmark, Gunnel, Sivils, K. L., Lessard, C., Li, H., Ice, J. A., Adrianto, I., Rasmussen, A., Lewis, D. M., Radfar, L., Stone, D. U., Montgomery, C. G., Rhodus, N. L., Scofield, R. H., Farris, A. D., Omdal, R., Wahren-Herlenius, M., Alevizos, I., Witte, T., Jonsson, R., Rischmueller, M., Rönnblom, Lars, Mariette, X., Ng, W. -F, Nordmark, Gunnel, and Sivils, K. L.
- Published
- 2016
- Full Text
- View/download PDF
17. AB0142 Sjögren's Syndrome-Associated Transcripts Show Correlation with Objective Measures of Dryness
- Author
-
Ice, J.A., primary, Adrianto, I., additional, Rasmussen, A., additional, Stone, D.U., additional, Segal, B.M., additional, Rhodus, N.L., additional, Radfar, L., additional, Montgomery, C.G., additional, Scofield, R.H., additional, Sivils, K.L., additional, and Lessard, C.J., additional
- Published
- 2016
- Full Text
- View/download PDF
18. OP0081 Identification of a Sjögren's Syndrome-Associated Variant that Influences OAS1 Isoform Switching and Protein Expression
- Author
-
Lessard, C., primary, Li, H., additional, Ice, J.A., additional, Adrianto, I., additional, Montgomery, C.G., additional, Alevizos, I., additional, Witte, T., additional, Rischmueller, M., additional, Wahren-Herlenius, M., additional, Omdal, R., additional, Jonsson, R., additional, Rhodus, N.L., additional, Ng, W.-F., additional, Nordmark, G., additional, and Sivils, K.L., additional
- Published
- 2015
- Full Text
- View/download PDF
19. SAT0371 Characterization of a SjÖgren's Syndrome-Associated Long Non-Coding RNA at 2P25.1
- Author
-
Ice, J.A., primary, Adrianto, I., additional, Li, H., additional, Rasmussen, A., additional, Wiley, G.B., additional, Stone, D.U., additional, Segal, B.M., additional, Rhodus, N.L., additional, Radfar, L., additional, James, J.A., additional, Montgomery, C.G., additional, Scofield, R.H., additional, Gaffney, P.M., additional, Thompson, L.F., additional, Farris, A.D., additional, Kovats, S., additional, Wren, J.D., additional, Sivils, K.L., additional, and Lessard, C.J., additional
- Published
- 2015
- Full Text
- View/download PDF
20. Identification of Multiple Sjogren'S Syndrome Susceptibility Loci
- Author
-
Lessard, C. J., Li, H., Ice, J. A., Adrianto, I., Jonsson, R., Illei, G. G., Rischmueller, M., Nordmark, Gunnel, Mariette, X., Miceli-Richard, C., Herlenius, M. Wahren, Witte, T., Brennan, M., Omdal, R., Gaffney, P. M., Lessard, J. A., Rönnblom, Lars, Ng, W. -F, Rhodus, N., Segal, B., Scofield, R. H., James, J. A., Anaya, J. -M, Montgomery, C. G., Harley, J. B., Sivils, K. Moser, Lessard, C. J., Li, H., Ice, J. A., Adrianto, I., Jonsson, R., Illei, G. G., Rischmueller, M., Nordmark, Gunnel, Mariette, X., Miceli-Richard, C., Herlenius, M. Wahren, Witte, T., Brennan, M., Omdal, R., Gaffney, P. M., Lessard, J. A., Rönnblom, Lars, Ng, W. -F, Rhodus, N., Segal, B., Scofield, R. H., James, J. A., Anaya, J. -M, Montgomery, C. G., Harley, J. B., and Sivils, K. Moser
- Published
- 2013
- Full Text
- View/download PDF
21. A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus
- Author
-
Wang, Shanshan, Adrianto, I., Wiley, G., Lessard, C. J., Kelly, J. A., Adler, A. J., Glenn, S. B., Williams, A. H., Ziegler, Julie, Comeau, M. E., Marion, M. C., Wakeland, B. E., Liang, C., Kaufman, K. M., Guthridge, J. M., Alarcón-Riquelme, M. E., Alarcón, G. S., Anaya, J. M., Bae, S. C., Kim, J. H., Joo, Y. B., Boackle, S. A., Brown, E. E., Petri, M., Ramsey-Goldman, R., Reveille, J. D., Vilá, Luis M., Criswell, L. A., Edberg, J. C., Freedman, Barry I., Gilkeson, G. S., Jacob, C. O., James, J. A., Kamen, D. L., Kimberly, R. P., Martín, J., Merrill, J. T., Niewold, T. B., Pons-Estel, B. A., Scofield, R. H., Stevens, A. M., Tsao, B. P., Vyse, T. J., Langefeld, C. D., Harley, J. B., Wakeland, E. K., Moser, K. L., Montgomery, C. G., Gaffney, P. M., Wang, Shanshan, Adrianto, I., Wiley, G., Lessard, C. J., Kelly, J. A., Adler, A. J., Glenn, S. B., Williams, A. H., Ziegler, Julie, Comeau, M. E., Marion, M. C., Wakeland, B. E., Liang, C., Kaufman, K. M., Guthridge, J. M., Alarcón-Riquelme, M. E., Alarcón, G. S., Anaya, J. M., Bae, S. C., Kim, J. H., Joo, Y. B., Boackle, S. A., Brown, E. E., Petri, M., Ramsey-Goldman, R., Reveille, J. D., Vilá, Luis M., Criswell, L. A., Edberg, J. C., Freedman, Barry I., Gilkeson, G. S., Jacob, C. O., James, J. A., Kamen, D. L., Kimberly, R. P., Martín, J., Merrill, J. T., Niewold, T. B., Pons-Estel, B. A., Scofield, R. H., Stevens, A. M., Tsao, B. P., Vyse, T. J., Langefeld, C. D., Harley, J. B., Wakeland, E. K., Moser, K. L., Montgomery, C. G., and Gaffney, P. M.
- Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease with diverse clinical manifestations characterized by the development of pathogenic autoantibodies manifesting in inflammation of target organs such as the kidneys, skin and joints. Genome-wide association studies have identified genetic variants in the UBE2L3 region that are associated with SLE in subjects of European and Asian ancestry. UBE2L3 encodes an ubiquitin-conjugating enzyme, UBCH7, involved in cell proliferation and immune function. In this study, we sought to further characterize the genetic association in the region of UBE2L3 and use molecular methods to determine the functional effect of the risk haplotype. We identified significant associations between variants in the region of UBE2L3 and SLE in individuals of European and Asian ancestry that exceeded a Bonferroni-corrected threshold (P<1 × 10 -4). A single risk haplotype was observed in all associated populations. Individuals harboring the risk haplotype display a significant increase in both UBE2L3 mRNA expression (P=0.0004) and UBCH7 protein expression (P=0.0068). The results suggest that variants carried on the SLE-associated UBE2L3 risk haplotype influence autoimmunity by modulating UBCH7 expression. © 2012 Macmillan Publishers Limited All rights reserved.
- Published
- 2012
22. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis
- Author
-
Lin, C. P., Adrianto, I., Lessard, C. J., Kelly, J. A., Kaufman, K. M., Guthridge, J. M., Freedman, Barry I., Anaya, J. M., Alarcón-Riquelme, M. E., Pons-Estel, B. A., Martín, J., Glenn, S. B., Petri, M., Criswell, L. A., Ramsey-Goldman, R., Reveille, J. D., Vilá, Luis M., Gilkeson, G. S., Kamen, D. L., Ziegler, Julie, Jacob, C. O., Rasmussen, A., James, J. A., Kimberly, R. P., Merrill, J. T., Niewold, T. B., Scofield, R. H., Stevens, A. M., Tsao, B. P., Vyse, T. J., Langefeld, C. D., Moser, K. L., Harley, J. B., Gaffney, P. M., Montgomery, C. G., Lin, C. P., Adrianto, I., Lessard, C. J., Kelly, J. A., Kaufman, K. M., Guthridge, J. M., Freedman, Barry I., Anaya, J. M., Alarcón-Riquelme, M. E., Pons-Estel, B. A., Martín, J., Glenn, S. B., Petri, M., Criswell, L. A., Ramsey-Goldman, R., Reveille, J. D., Vilá, Luis M., Gilkeson, G. S., Kamen, D. L., Ziegler, Julie, Jacob, C. O., Rasmussen, A., James, J. A., Kimberly, R. P., Merrill, J. T., Niewold, T. B., Scofield, R. H., Stevens, A. M., Tsao, B. P., Vyse, T. J., Langefeld, C. D., Moser, K. L., Harley, J. B., Gaffney, P. M., and Montgomery, C. G.
- Abstract
Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by autoantibody production and organ damage. Lupus nephritis (LN) is one of the most severe manifestations of SLE. Multiple studies reported associations between renal diseases and variants in the non-muscle myosin heavy chain 9 (MYH9) and the neighboring apolipoprotein L 1 (APOL1) genes. We evaluated 167 variants spanning MYH9 for association with LN in a multiethnic sample. The two previously identified risk variants in APOL1 were also tested for association with LN in European-Americans (EAs) (N=579) and African-Americans (AAs) (N=407). Multiple peaks of association exceeding a Bonferroni corrected P-value of P<2.03 × 10 -3 were observed between LN and MYH9 in EAs (N=4620), with the most pronounced association at rs2157257 (P=4.7 × 10 -4, odds ratio (OR)=1.205). A modest effect with MYH9 was also detected in Gullah (rs8136069, P=0.0019, OR=2.304). No association between LN and MYH9 was found in AAs, Asians, Amerindians or Hispanics. This study provides the first investigation of MYH9 in LN in non-Africans and of APOL1 in LN in any population, and presents novel insight into the potential role of MYH9 in LN in EAs. © 2012 Macmillan Publishers Limited All rights reserved.
- Published
- 2012
23. Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study
- Author
-
Lessard, C. J., Adrianto, I., Kelly, J. A., Kaufman, K. M., Grundahl, K. M., Adler, A. J., Williams, A. H., Gallant, C., Anaya, J. M., Bae, S. C., Boackle, S. A., Brown, E. E., Chang, D. M., Criswell, L. A., Edberg, J. C., Freedman, Barry I., Gregersen, Peter K., Gilkeson, G. S., Jacob, C. O., James, J. A., Kamen, D. L., Kimberly, R. P., Martín, J., Merrill, J. T., Niewold, T. B., Park, Su-Yeon, Petri, M., Pons-Estel, B. A., Ramsey-Goldman, R., Reveille, J. D., Song, Y. W., Stevens, A. M., Tsao, B. P., Vilá, Luis M., Vyse, T. J., Yu, C. Y., Guthridge, J. M., Bruner, G. R., Langefeld, C. D., Montgomery, C. G., Harley, J. B., Scofield, R. H., Gaffney, P. M., Moser, K. L., Lessard, C. J., Adrianto, I., Kelly, J. A., Kaufman, K. M., Grundahl, K. M., Adler, A. J., Williams, A. H., Gallant, C., Anaya, J. M., Bae, S. C., Boackle, S. A., Brown, E. E., Chang, D. M., Criswell, L. A., Edberg, J. C., Freedman, Barry I., Gregersen, Peter K., Gilkeson, G. S., Jacob, C. O., James, J. A., Kamen, D. L., Kimberly, R. P., Martín, J., Merrill, J. T., Niewold, T. B., Park, Su-Yeon, Petri, M., Pons-Estel, B. A., Ramsey-Goldman, R., Reveille, J. D., Song, Y. W., Stevens, A. M., Tsao, B. P., Vilá, Luis M., Vyse, T. J., Yu, C. Y., Guthridge, J. M., Bruner, G. R., Langefeld, C. D., Montgomery, C. G., Harley, J. B., Scofield, R. H., Gaffney, P. M., and Moser, K. L.
- Abstract
Systemic lupus erythematosus (SLE) is considered to be the prototypic autoimmune disease, with a complex genetic architecture influenced by environmental factors. We sought to replicate a putative association at 11p13 not yet exceeding genome-wide significance (p < 5 × 10-8) identified in a genome-wide association study (GWAS). Our GWA scan identified two intergenic SNPs located between PDHX and CD44 showing suggestive evidence of association with SLE in cases of European descent (rs2732552, p = 0.004, odds ratio [OR] = 0.78; rs387619, p = 0.003, OR = 0.78). The replication cohort consisted of >15,000 subjects, including 3562 SLE cases and 3491 controls of European ancestry, 1527 cases and 1811 controls of African American (AA) descent, and 1265 cases and 1260 controls of Asian origin. We observed robust association at both rs2732552 (p = 9.03 × 10-8, OR = 0.83) and rs387619 (p = 7.7 × 10-7, OR = 0.83) in the European samples with pmeta = 1.82 × 10-9 for rs2732552. The AA and Asian SLE cases also demonstrated association at rs2732552 (p = 5 × 10-3, OR = 0.81 and p = 4.3 × 10-4, OR = 0.80, respectively). A meta-analysis of rs2732552 for all racial and ethnic groups studied produced pmeta = 2.36 × 10-13. This locus contains multiple regulatory sites that could potentially affect expression and functions of CD44, a cell-surface glycoprotein influencing immunologic, inflammatory, and oncologic phenotypes, or PDHX, a subunit of the pyruvate dehydrogenase complex. © 2011 The American Society of Human Genetics.
- Published
- 2011
24. OP0020 Identification of Multiple Sjögren’s Syndrome Susceptibility Loci
- Author
-
Lessard, C. J., primary, Li, H., additional, Ice, J. A., additional, Adrianto, I., additional, Jonsson, R., additional, Illei, G. G., additional, Rischmueller, M., additional, Nordmark, G., additional, Mariette, X., additional, Miceli-Richard, C., additional, Wahren Herlenius, M., additional, Witte, T., additional, Brennan, M., additional, Omdal, R., additional, Gaffney, P. M., additional, Lessard, J. A., additional, Rönnblom, L., additional, Ng, W.-F., additional, Rhodus, N., additional, Segal, B., additional, Scofield, R. H., additional, James, J. A., additional, Anaya, J.-M., additional, Montgomery, C. G., additional, Harley, J. B., additional, and Moser Sivils, K., additional
- Published
- 2013
- Full Text
- View/download PDF
25. Active learning with support vector machines for tornado prediction
- Author
-
Theodore Trafalis, Adrianto, I., and Richman, M. B.
26. Antibodies to periodontogenic bacteria are associated with higher disease activity in lupus patients
- Author
-
Bagavant, H., Dunkleberger, M. L., Wolska, N., Sroka, M., Rasmussen, A., Adrianto, I., Courtney Montgomery, Sivils, K., Guthridge, J. M., James, J. A., Merrill, J. T., and Deshmukh, U. S.
27. A spatiotemporal approach to tornado prediction.
- Author
-
Lakshmanan, V., Adrianto, I., Smith, T., and Stumpf, G.
- Published
- 2005
- Full Text
- View/download PDF
28. Infliximab shows superior drug survival among biologics for hidradenitis suppurativa: A cohort study.
- Author
-
Young AT, Lu K, Dai A, Hamzavi I, Huggins RH, Adrianto I, Zhou L, and Mi QS
- Abstract
Competing Interests: Conflicts of interest Dr Hamzavi is a consultant for AbbVie, Pfizer, Incyte, UCB, Boehringer Ingelheim, Sonoma, Union Therapeutics, Novartis, Jansen, Avita, and Galderma; investigator for Lenicura, Pfizer, Incyte, Avita, and L'Oréal/La Roche-Posay; and past president of the HS Foundation and Global Vitiligo Foundation. Dr Huggins has been an investigator for Arcutis, Avita, Clinuvel, Incyte, Pfizer, Mitsubishi, and The Immune Tolerance Network. He is also the Treasurer of the Global Vitiligo Foundation (GVF) and the chair of the GVF community committee and served on advisory boards for Incyte and Avita. Drs Young, Adrianto, Zhou, and Mi and authors Lu and Dai have no conflicts of interest to declare.
- Published
- 2024
- Full Text
- View/download PDF
29. Cellular indexing of transcriptomes and epitopes (CITE-Seq) in hidradenitis suppurativa identifies dysregulated cell types in peripheral blood and facilitates diagnosis via machine learning.
- Author
-
Kumar S, Orcales F, Shih BB, Fang X, Yin C, Yates A, Dimitrion P, Neuhaus I, Johnson C, Adrianto I, Wiala A, Hamzavi I, Zhou L, Naik H, Posch C, Mi QS, and Liao W
- Abstract
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by painful nodules, abscesses, and scarring, predominantly affecting intertriginous regions and it is often underdiagnosed. This study aimed to utilize single cell RNA and cell-surface protein sequencing (CITE-Seq) to delineate the immune composition of circulating cells in Hidradenitis suppurativa (HS) peripheral blood compared to healthy controls. CITE-Seq was used to analyze the gene and protein expression profiles of peripheral blood mononuclear cells (PBMCs) from 9 HS and 29 healthy controls. The study identified significant differences cell composition between HS patients and healthy controls, including increased proportions of CD14+ and CD16+ monocytes, cDC2, plasmablasts, and proliferating CD4+ T cells in HS patients. Differential expression analysis revealed upregulation of inflammatory markers such as TNF, IL1B , and NF-κB in monocytes, as well as chemokines and cell adhesion molecules involved in immune cell recruitment and tissue infiltration. Pathway enrichment analysis highlighted the involvement of IL-17, IL-26 and TNF signaling pathways in HS pathogenesis. Machine learning identified key markers for diagnostics and therapeutic development. The findings also support the potential for machine learning models to aid in the diagnosis of HS based on immune cell markers. These insights may inform future therapeutic strategies targeting specific immune pathways in HS., Competing Interests: Conflict of Interest WL has received research grant funding from Abbvie, Amgen, Janssen, Leo, Novartis, Pfizer, Regeneron, and TRex Bio. CP has received honoraria and/or travel support from MSD, BMS, Pierre Fabre, MERCK, Sanofi, Almirall, AbbVie, Pelpharma, Amgen, DSD, Takeda, Pfizer, Novartis, Leo, Janssen, Astra Zeneca, and Boehringer Ingelheim. AW received honoraria and travel support from AbbVie, Amgen, Biogen, Janssen, Leo, Novartis, UCB and Sanofi. HN has received grant support from AbbVie; consulting fees from 23andme, Abbvie, Aristea Therapeutics, Nimbus Therapeutics, Medscape, Sonoma Biotherapeutics, DAVA Oncology, Boehringer Ingelheim, Union Chimique Belge’s (UCB) and Novartis; investigator fees from Pfizer; and holds shares in Radera, Inc. She is also an Associate Editor for JAMA Dermatology and Vice President of the Hidradenitis Suppurativa Foundation. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF
30. Corrigendum to "scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic cancer liver metastasis" [Cancer Lett. (2023 May 1) 561 216149].
- Author
-
Yi Q, Wang J, Liu T, Yao Y, Loveless I, Subedi K, Toor J, Adrianto I, Xiao H, Chen B, Crawford HC, Fang D, Zhou L, and Mi QS
- Published
- 2024
- Full Text
- View/download PDF
31. Synergistic effects of social determinants of health and race-ethnicity on 30-day all-cause readmission disparities: a retrospective cohort study.
- Author
-
Su WK, Cannella C, Haeusler J, Adrianto I, Rubinfeld I, and Levin AM
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Ethnicity statistics & numerical data, Health Status Disparities, Healthcare Disparities ethnology, Healthcare Disparities statistics & numerical data, Michigan, Retrospective Studies, United States, Racial Groups statistics & numerical data, Patient Readmission statistics & numerical data, Social Determinants of Health ethnology
- Abstract
Objective: The objective of this study is to assess the effects of social determinants of health (SDOH) and race-ethnicity on readmission and to investigate the potential for geospatial clustering of patients with a greater burden of SDOH that could lead to a higher risk of readmission., Design: A retrospective study of inpatients at five hospitals within Henry Ford Health (HFH) in Detroit, Michigan from November 2015 to December 2018 was conducted., Setting: This study used an adult inpatient registry created based on HFH electronic health record data as the data source. A subset of the data elements in the registry was collected for data analyses that included readmission index, race-ethnicity, six SDOH variables and demographics and clinical-related variables., Participants: The cohort was composed of 248 810 admission patient encounters with 156 353 unique adult patients between the study time period. Encounters were excluded if they did not qualify as an index admission for all payors based on the Centers for Medicare and Medicaid Service definition., Main Outcome Measure: The primary outcome was 30-day all-cause readmission. This binary index was identified based on HFH internal data supplemented by external validated readmission data from the Michigan Health Information Network., Results: Race-ethnicity and all SDOH were significantly associated with readmission. The effect of depression on readmission was dependent on race-ethnicity, with Hispanic patients having the strongest effect in comparison to either African Americans or non-Hispanic whites. Spatial analysis identified ZIP codes in the City of Detroit, Michigan, as over-represented for individuals with multiple SDOH., Conclusions: There is a complex relationship between SDOH and race-ethnicity that must be taken into consideration when providing healthcare services. Insights from this study, which pinpoint the most vulnerable patients, could be leveraged to further improve existing models to predict risk of 30-day readmission for individuals in future work., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
32. The Hidradenitis Suppurativa Omics Database (HS-OmicsDB).
- Author
-
Dimitrion P, Loveless I, Zhou L, Mi QS, and Adrianto I
- Subjects
- Humans, Severity of Illness Index, Hidradenitis Suppurativa epidemiology, Hidradenitis Suppurativa genetics
- Published
- 2024
- Full Text
- View/download PDF
33. Distinguishing Keratoacanthoma from Well-Differentiated Cutaneous Squamous Cell Carcinoma Using Single-Cell Spatial Pathology.
- Author
-
Veenstra J, Ozog D, Loveless I, Adrianto I, Dimitrion P, Subedi K, Friedman BJ, Zhou L, and Mi QS
- Subjects
- Humans, Ki-67 Antigen, Keratinocytes, Carcinoma, Squamous Cell diagnosis, Carcinoma, Squamous Cell genetics, Keratoacanthoma diagnosis, Keratoacanthoma genetics, Skin Neoplasms diagnosis, Skin Neoplasms genetics
- Abstract
Keratoacanthoma (KA) is a common keratinocyte neoplasm that is regularly classified as a type of cutaneous squamous cell carcinoma (cSCC) despite demonstrating benign behavior. Differentiating KA from well-differentiated cSCC is difficult in many cases due to the substantial overlap of clinical and histological features. Currently, no reliable discriminating markers have been defined, and consequently, KAs are often treated similarly to cSCC, creating unnecessary surgical morbidity and healthcare costs. In this study, we used RNA sequencing to identify key differences in transcriptomes between KA and cSCC, which suggested divergent keratinocyte populations between each tumor. Imaging mass cytometry was then used to identify single-cell tissue characteristics, including cellular phenotype, frequency, topography, functional status, and interactions between KA and well-differentiated cSCC. We found that cSCC had significantly increased proportions of Ki67+ keratinocytes among tumor keratinocytes, which were dispersed significantly throughout non-basal keratinocyte communities. In cSCC, regulatory T-cells were more prevalent and held greater suppressive capacity. Furthermore, cSCC regulatory T-cells, tumor-associated macrophages, and fibroblasts had significant associations with Ki67
+ keratinocytes as opposed to avoidances with KA, indicating a more immunosuppressive environment. Our data suggest that multicellular spatial features can serve as a foundation to enhance the histological discrimination of ambiguous KA and cSCC lesions., (Copyright © 2023. Published by Elsevier Inc.)- Published
- 2023
- Full Text
- View/download PDF
34. Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.
- Author
-
Wiley MM, Khatri B, Joachims ML, Tessneer KL, Stolarczyk AM, Rasmussen A, Anaya JM, Aqrawi LA, Bae SC, Baecklund E, Björk A, Brun JG, Bucher SM, Dand N, Eloranta ML, Engelke F, Forsblad-d'Elia H, Fugmann C, Glenn SB, Gong C, Gottenberg JE, Hammenfors D, Imgenberg-Kreuz J, Jensen JL, Johnsen SJA, Jonsson MV, Kelly JA, Khanam S, Kim K, Kvarnström M, Mandl T, Martín J, Morris DL, Nocturne G, Norheim KB, Olsson P, Palm Ø, Pers JO, Rhodus NL, Sjöwall C, Skarstein K, Taylor KE, Tombleson P, Thorlacius GE, Venuturupalli S, Vital EM, Wallace DJ, Grundahl KM, Radfar L, Brennan MT, James JA, Scofield RH, Gaffney PM, Criswell LA, Jonsson R, Appel S, Eriksson P, Bowman SJ, Omdal R, Rönnblom L, Warner BM, Rischmueller M, Witte T, Farris AD, Mariette X, Shiboski CH, Wahren-Herlenius M, Alarcón-Riquelme ME, Ng WF, Sivils KL, Guthridge JM, Adrianto I, Vyse TJ, Tsao BP, Nordmark G, and Lessard CJ
- Abstract
Fine mapping and bioinformatic analysis of the DDX6-CXCR5 genetic risk association in Sjögren's Disease (SjD) and Systemic Lupus Erythematosus (SLE) identified five common SNPs with functional evidence in immune cell types: rs4938573, rs57494551, rs4938572, rs4936443, rs7117261. Functional interrogation of nuclear protein binding affinity, enhancer/promoter regulatory activity, and chromatin-chromatin interactions in immune, salivary gland epithelial, and kidney epithelial cells revealed cell type-specific allelic effects for all five SNPs that expanded regulation beyond effects on DDX6 and CXCR5 expression. Mapping the local chromatin regulatory network revealed several additional genes of interest, including lnc-PHLDB1-1 . Collectively, functional characterization implicated the risk alleles of these SNPs as modulators of promoter and/or enhancer activities that regulate cell type-specific expression of DDX6 , CXCR5 , and lnc-PHLDB1-1 , among others. Further, these findings emphasize the importance of exploring the functional significance of SNPs in the context of complex chromatin architecture in disease-relevant cell types and tissues., Competing Interests: Competing Interests C.J.L.* and A.D.F. have an active collaborative research agreement with Janssen. E.B. has an active research collaboration with Pfizer. T.M. is employed as medical solutions lead in rheumatology at UCB. R.H.S. is a consultant for Jansen Pharmaceuticals. S.J.B. provided consultancy services for Abbvie, BMS, Galapagos, Iqvia, J&J, Kiniksa, and Novartis in 2020–2021. L.R. provided consultancy services for AstraZeneca. B.M.W. has active collaborative research agreements with Astellas Bio and Pfizer, Inc. M.R. received grants from Amgen, AstraZeneca, Bristol Myers-Squibb, Novartis, and Servier for clinical trials in Sjögren’s Syndrome and SLE. All other authors have reported that they have no competing interests to report.
- Published
- 2023
- Full Text
- View/download PDF
35. Identification of Environmental Exposures Associated with Risk of Sarcoidosis in African Americans.
- Author
-
Levin AM, She R, Chen Y, Adrianto I, Datta I, Loveless IM, Garman L, Montgomery CG, Li J, Iannuzzi MC, and Rybicki BA
- Subjects
- Humans, Black People, Environmental Exposure adverse effects, Black or African American, Sarcoidosis epidemiology, Sarcoidosis genetics
- Abstract
Rationale: Sarcoidosis is a racially disparate granulomatous disease likely caused by environmental exposures, genes, and their interactions. Despite increased risk in African Americans, few environmental risk factor studies in this susceptible population exist. Objectives: To identify environmental exposures associated with the risk of sarcoidosis in African Americans and those that differ in effect by self-identified race and genetic ancestry. Methods: The study sample comprised 2,096 African Americans (1,205 with and 891 without sarcoidosis) compiled from three component studies. Unsupervised clustering and multiple correspondence analyses were used to identify underlying clusters of environmental exposures. Mixed-effects logistic regression was used to evaluate the association of these exposure clusters and the 51 single-component exposures with risk of sarcoidosis. A comparison case-control sample of 762 European Americans (388 with and 374 without sarcoidosis) was used to assess heterogeneity in exposure risk by race. Results: Seven exposure clusters were identified, five of which were associated with risk. The exposure cluster with the strongest risk association was composed of metals ( P < 0.001), and within this cluster, exposure to aluminum had the highest risk (odds ratio, 3.30; 95% confidence interval [95% CI], 2.23-4.09; P < 0.001). This effect also differed by race ( P < 0.001), with European Americans having no significant association with exposure (odds ratio, 0.86; 95% CI, 0.56-1.33). Within African Americans, the increased risk was dependent on genetic African ancestry ( P = 0.047). Conclusions: Our findings support African Americans having sarcoidosis environmental exposure risk profiles that differ from those of European Americans. These differences may underlie racially disparate incidence rates that are partially explained by genetic variation differing by African ancestry.
- Published
- 2023
- Full Text
- View/download PDF
36. Mass cytometry uncovers a distinct peripheral immune profile and upregulated CD38 expression in patients with hidradenitis suppurativa.
- Author
-
Dimitrion P, Hamzavi I, Yin C, Toor J, Subedi K, Khalasawi N, Miller A, Huggins R, Adrianto I, Veenstra J, Vellaichamy G, Hans A, Daveluy S, Athar M, Liao W, Lim H, Ozog D, Zhou L, and Mi QS
- Subjects
- Humans, Hidradenitis Suppurativa
- Published
- 2023
- Full Text
- View/download PDF
37. Integrative scATAC-seq and scRNA-seq analyses map thymic iNKT cell development and identify Cbfβ for its commitment.
- Author
-
Wang J, Adrianto I, Subedi K, Liu T, Wu X, Yi Q, Loveless I, Yin C, Datta I, Sant'Angelo DB, Kronenberg M, Zhou L, and Mi QS
- Abstract
Unlike conventional αβT cells, invariant natural killer T (iNKT) cells complete their terminal differentiation to functional iNKT1/2/17 cells in the thymus. However, underlying molecular programs that guide iNKT subset differentiation remain unclear. Here, we profiled the transcriptomes of over 17,000 iNKT cells and the chromatin accessibility states of over 39,000 iNKT cells across four thymic iNKT developmental stages using single-cell RNA sequencing (scRNA-seq) and single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq) to define their developmental trajectories. Our study discovered novel features for iNKT precursors and different iNKT subsets and indicated that iNKT2 and iNKT17 lineage commitment may occur as early as stage 0 (ST0) by two distinct programs, while iNKT1 commitments may occur post ST0. Both iNKT1 and iNKT2 cells exhibit extensive phenotypic and functional heterogeneity, while iNKT17 cells are relatively homogenous. Furthermore, we identified that a novel transcription factor, Cbfβ, was highly expressed in iNKT progenitor commitment checkpoint, which showed a similar expression trajectory with other known transcription factors for iNKT cells development, Zbtb16 and Egr2, and could direct iNKT cells fate and drive their effector phenotype differentiation. Conditional deletion of Cbfβ blocked early iNKT cell development and led to severe impairment of iNKT1/2/17 cell differentiation. Overall, our findings uncovered distinct iNKT developmental programs as well as their cellular heterogeneity, and identified a novel transcription factor Cbfβ as a key regulator for early iNKT cell commitment., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
38. Sex-biased immunological processes drive hidradenitis suppurativa.
- Author
-
Young KZ, Dimitrion P, Zhou L, Adrianto I, and Mi QS
- Subjects
- Male, Humans, Female, Sexism, Cytokines, Th17 Cells, Abscess, Hidradenitis Suppurativa etiology
- Abstract
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that can manifest with abscesses, sinus tracts, and scarring in the intertriginous areas of the body. HS is characterized by immune dysregulation, featuring elevated levels of myeloid cells, T helper (Th) cells, and pro-inflammatory cytokines, particularly those involved in Th1- and Th17-mediated immunity. In most epidemiological studies, HS shows a strong female sex bias, with reported female-to-male ratios estimated at roughly 3:1, suggesting that sex-related factors contribute to HS pathophysiology. In this article, we review the role of intrinsic and extrinsic factors that contribute to immunological differences between the sexes and postulate their role in the female sex bias observed in HS. We discuss the effects of hormones, X chromosome dosage, genetics, the microbiome, and smoking on sex-related differences in immunity to postulate potential immunological mechanisms in HS pathophysiology. Future studies are required to better characterize sex-biased factors that contribute to HS disease presentations., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Young, Dimitrion, Zhou, Adrianto and Mi.)
- Published
- 2023
- Full Text
- View/download PDF
39. scRNA-Seq and imaging mass cytometry analyses unveil iNKT cells-mediated anti-tumor immunity in pancreatic cancer liver metastasis.
- Author
-
Yi Q, Wang J, Liu T, Yao Y, Loveless I, Subedi K, Toor J, Adrianto I, Xiao H, Chen B, Crawford HC, Fang D, Zhou L, and Mi QS
- Subjects
- Animals, Mice, Humans, Epithelial-Mesenchymal Transition, Single-Cell Gene Expression Analysis, Image Cytometry, Lymphocyte Activation, Tumor Microenvironment, Natural Killer T-Cells, Liver Neoplasms genetics, Liver Neoplasms metabolism, Pancreatic Neoplasms genetics, Pancreatic Neoplasms metabolism
- Abstract
Invariant natural killer T (iNKT) cells are innate-like T cells that are abundant in liver sinusoids and play a critical role in tumor immunity. However, the role of iNKT cells in pancreatic cancer liver metastasis (PCLM) has not been fully explored. In this study, we employed a hemi-spleen pancreatic tumor cell injection mouse model of PCLM, a model that closely mimics clinical conditions in humans, to explore the role of iNKT cells in PCLM. Activation of iNKT cells with α-galactosylceramide (αGC) markedly increased immune cell infiltration and suppressed PCLM progression. Via single cell RNA sequencing (scRNA-seq) we profiled over 30,000 immune cells from normal liver and PCLM with or without αGC treatment and were able to characterize the global changes of the immune cells in the tumor microenvironment upon αGC treatment, identifying a total of 12 subpopulations. Upon treatment with αGC, scRNA-Seq and flow cytometry analyses revealed increased cytotoxic activity of iNKT/NK cells and skewing CD4 T cells towards a cytotoxic Th1 profile and CD8 T cells towards a cytotoxic profile, characterized by higher proliferation and reduced exhaustion marker PD1 expression. Moreover, αGC treatment excluded tumor associated macrophages. Lastly, imaging mass cytometry analysis uncovered the reduced epithelial to mesenchymal transition related markers and increased active CD4 and CD8 T cells in PCLM with αGC treatment. Overall, our findings uncover the protective function of activated iNKT cells in pancreatic cancer liver metastasis through increased NK and T cell immunity and decreased tumor associated macrophages., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2023
- Full Text
- View/download PDF
40. Urine Cell Transcriptomes Implicate Specific Renal Inflammatory Pathways Associated With Difficult-to-Control Hypertension.
- Author
-
Umanath K, She R, Hassett C, Adrianto I, Levin AM, Savickas G, Yee J, and Ortiz P
- Subjects
- Humans, Transcriptome, Blood Pressure physiology, Antihypertensive Agents therapeutic use, Antihypertensive Agents pharmacology, Inflammation complications, Hypertension drug therapy, Nephritis genetics, Nephritis complications
- Abstract
Background The renal mechanisms involved in the maintenance of human hypertension and resistance to treatment are not well understood. Animal studies suggest that chronic renal inflammation contributes to hypertension. We studied cells shed in first-morning urine samples from individuals who were hypertensive who exhibited difficult-to-control blood pressure (BP). We performed bulk RNA sequencing of these shed cells to develop transcriptome-wide associations with BP. We also analyzed nephron-specific genes and used an unbiased bioinformatic approach to find signaling pathways activated in difficult-to-control hypertension. Methods and Results Participants who completed the SPRINT (Systolic Blood Pressure Intervention Trial) at a single trial site were recruited, and cells shed in first-morning urine samples collected. A total of 47 participants were divided into 2 groups based on hypertension control. The BP-difficult group (n=29) had systolic BP>140 mm Hg, >120 mm Hg after intensive treatment for hypertension, or required more than the median number of antihypertensive drugs used in SPRINT. The easy-to-control BP group (n=18) comprised the remainder of the participants. A total of 60 differentially expressed genes were identified with a >2-fold change in the BP-difficult group. In BP-difficult participants, 2 of the most upregulated genes were associated with inflammation: Tumor Necrosis Factor Alpha Induced Protien 6 (fold change, 7.76; P =0.006) and Serpin Family B Member 9 (fold change, 5.10; P =0.007). Biological pathway analysis revealed an overrepresentation of inflammatory networks, including interferon signaling, granulocyte adhesion and diapedesis, and Janus Kinase family kinases in the BP-difficult group ( P <0.001). Conclusions We conclude that transcriptomes from cells shed in first-morning urine identify a gene expression profile in difficult-to-control hypertension that associates with renal inflammation.
- Published
- 2023
- Full Text
- View/download PDF
41. Dysregulated CD38 expression in blood and skin immune cells of patients with hidradenitis suppurativa.
- Author
-
Mi QS, Dimitrion P, Hamzavi I, Yin C, Loveless I, Toor J, Subedi K, Huggins R, Khalasawi N, Adrianto I, Veenstra J, Vellaichamy G, Hans A, Daveluy S, Athar M, Liao W, Lim H, Ozog D, and Zhou L
- Abstract
Hidradenitis suppurativa (HS) is a multifactorial, inflammatory skin disease. Increased systemic inflammatory comorbidities and serum cytokines highlight systemic inflammation as a feature of HS. However, the specific immune cell subsets contributing to systemic and cutaneous inflammation have not been resolved. Here, we generated whole-blood immunomes by mass cytometry. We performed a meta-analysis of RNA-seq data, immunohistochemistry, and imaging mass cytometry to characterize the immunological landscape of skin lesions and perilesions from patients with HS. Blood from patients with HS exhibited lower frequencies of natural killer cells, dendritic cells, and classical (CD14+CD16-) and nonclassical (CD14-CD16+) monocytes, as well as higher frequencies of Th17 cells and intermediate (CD14+CD16+) monocytes than blood from healthy controls. Classical and intermediate monocytes from patients with HS had increased expression of skin-homing chemokine receptors. Furthermore, we identified a CD38+ intermediate monocyte subpopulation that was more abundant in the immunome of blood from patients with HS. Meta-analysis of RNA-seq data found higher CD38 expression in lesional HS skin than in perilesional skin, and markers of classical monocyte infiltration. Imaging mass cytometry showed that CD38+ classical monocytes and CD38+ monocyte-derived macrophages were more abundant in lesional HS skin. Overall, we report targeting CD38 may be worth pursuing in clinical trials.
- Published
- 2023
- Full Text
- View/download PDF
42. Author Correction: Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells.
- Author
-
Khatri B, Tessneer KL, Rasmussen A, Aghakhanian F, Reksten TR, Adler A, Alevizos I, Anaya JM, Aqrawi LA, Baecklund E, Brun JG, Bucher SM, Eloranta ML, Engelke F, Forsblad-d'Elia H, Glenn SB, Hammenfors D, Imgenberg-Kreuz J, Jensen JL, Johnsen SJA, Jonsson MV, Kvarnström M, Kelly JA, Li H, Mandl T, Martín J, Nocturne G, Norheim KB, Palm Ø, Skarstein K, Stolarczyk AM, Taylor KE, Teruel M, Theander E, Venuturupalli S, Wallace DJ, Grundahl KM, Hefner KS, Radfar L, Lewis DM, Stone DU, Kaufman CE, Brennan MT, Guthridge JM, James JA, Scofield RH, Gaffney PM, Criswell LA, Jonsson R, Eriksson P, Bowman SJ, Omdal R, Rönnblom L, Warner B, Rischmueller M, Witte T, Farris AD, Mariette X, Alarcon-Riquelme ME, Shiboski CH, Wahren-Herlenius M, Ng WF, Sivils KL, Adrianto I, Nordmark G, and Lessard CJ
- Published
- 2023
- Full Text
- View/download PDF
43. Dysregulated CD38 expression in blood and skin immune cells of patients with hidradenitis suppurativa.
- Author
-
Dimitrion P, Hamzavi I, Yin C, Loveless I, Toor J, Subedi K, Khalasawi N, Miller A, Huggins R, Adrianto I, Veenstra J, Vellaichamy G, Hans A, Daveluy S, Athar M, Liao W, Lim H, Ozog D, Zhou L, and Mi QS
- Abstract
Background: Hidradenitis suppurativa (HS) is a multifactorial, inflammatory skin disease. Increased systemic inflammatory comorbidities and serum cytokines highlight systemic inflammation as a feature of HS. However, the specific immune cell subsets contributing to systemic and cutaneous inflammation have not been resolved., Objective: Identify features of peripheral and cutaneous immune dysregulation., Methods: Here, we generated whole-blood immunomes by mass cytometry. We performed a meta-analysis of RNA-seq data, immunohistochemistry, and imaging mass cytometry to characterize the immunological landscape of skin lesions and perilesions from patients with HS., Results: Blood from patients with HS exhibited lower frequencies of natural killer cells, dendritic cells, and classical (CD14+CD16-) and nonclassical (CD14-CD16+) monocytes, as well as higher frequencies of Th17 cells and intermediate (CD14+CD16+) monocytes than blood from healthy controls. Classical and intermediate monocytes from patients with HS had increased expression of skin-homing chemokine receptors. Furthermore, we identified a CD38+ intermediate monocyte subpopulation that was more abundant in the immunome of blood from patients with HS. Meta-analysis of RNA-seq data found higher CD38 expression in lesional HS skin than in perilesional skin, and markers of classical monocyte infiltration. Imaging mass cytometry showed that CD38+ classical monocytes and CD38+ monocyte-derived macrophages were more abundant in lesional HS skin., Conclusion: Overall, we report targeting CD38 may be worth pursuing in clinical trials., Key Messages: 3.Monocyte subsets express markers of activation in circulation and HS lesionsTargeting CD38 may be a viable strategy for treating systemic and cutaneous inflammation in patients with HS., Capsule Summary: 4.Dysregulated immune cells in patients with HS express CD38 and may be targeting by anti-CD38 immunotherapy.
- Published
- 2023
- Full Text
- View/download PDF
44. The Hidradenitis Suppurativa 'Omics Database (HS-OmicsDB).
- Author
-
Dimitrion P, Loveless I, Zhou L, Mi QS, and Adrianto I
- Abstract
Large scale meta-analyses of genomics and genetics have spurred research in a number of fields, such as cancer, genetics and immunology. Publicly available 'omics databases provide valuable hypothesis generating and validation tools. To date, no such initiative has been undertaken for Hidradenitis Suppurativa (HS), an inflammatory skin disease of unknown etiology. We present here, a longitudinal initiative seeking to aggregate publicly available 'omics data to enhance research efforts in HS. In its first iteration, we include bulk and single-cell RNA sequencing data from untreated HS patients. Our data, aggregated from publicly available GEO datasets provides a tool to profile gene expression in specific tissue types (i.e. lesional, perilesional, nonlesional and healthy skin) as well as map cell-specific gene expression on single-cell data from HS lesions.
- Published
- 2023
- Full Text
- View/download PDF
45. Dysregulated long non-coding RNA in Sjögren's disease impacts both interferon and adaptive immune responses.
- Author
-
Joachims ML, Khatri B, Li C, Tessneer KL, Ice JA, Stolarczyk AM, Means N, Grundahl KM, Glenn SB, Kelly JA, Lewis DM, Radfar L, Stone DU, Guthridge JM, James JA, Scofield RH, Wiley GB, Wren JD, Gaffney PM, Montgomery CG, Sivils KL, Rasmussen A, Farris AD, Adrianto I, and Lessard CJ
- Subjects
- Humans, Interferons, Calcineurin, Antiviral Agents, Autoantibodies, Immunity, Receptors, Antigen, T-Cell, RNA, Long Noncoding genetics, Sjogren's Syndrome genetics, Autoimmune Diseases
- Abstract
Objective: Sjögren's disease (SjD) is an autoimmune disease characterised by inflammatory destruction of exocrine glands. Patients with autoantibodies to Ro/SSA (SjD
Ro+ ) exhibit more severe disease. Long non-coding RNAs (lncRNAs) are a functionally diverse class of non-protein-coding RNAs whose role in autoimmune disease pathology has not been well characterised., Methods: Whole blood RNA-sequencing (RNA-seq) was performed on SjD cases (n=23 Ro/SSA negative (SjDRo- ); n=27 Ro/SSA positive (SjDRo+ ) and healthy controls (HCs; n=27). Bioinformatics and pathway analyses of differentially expressed (DE) transcripts (log2 fold change ≥2 or ≤0.5; padj <0.05) were used to predict lncRNA function. LINC01871 was characterised by RNA-seq analyses of HSB-2 cells with CRISPR-targeted LINC01871 deletion ( LINC01871-/ - ) and in vitro stimulation assays., Results: Whole blood RNA-seq revealed autoantibody-specific transcription profiles and disproportionate downregulation of DE transcripts in SjD cases relative to HCs. Sixteen DE lncRNAs exhibited correlated expression with the interferon (IFN)-regulated gene, RSAD2 , in SjDRo+ (r≥0.65 or ≤-0.6); four antisense lncRNAs exhibited IFN-regulated expression in immune cell lines. LINC01871 was upregulated in all SjD cases. RNA-seq and pathway analyses of LINC01871-/ - cells implicated roles in cytotoxic function, differentiation and IFNγ induction. LINC01871 was induced by IFNγ in a myeloid cell line and regulated by calcineurin/NFAT pathway and T cell receptor (TCR) signalling in primary human T cells., Conclusion: LINC01871 influences expression of many immune cell genes and growth factors, is IFNγ inducible, and regulated by calcineurin signalling and TCR ligand engagement. Altered LINC01871 expression may influence the dysregulated T cell inflammatory pathways implicated in SjD., Competing Interests: Competing interests: KS is a current employee of Janssen. ADF and CJL have an active collaborative research agreement with Janssen. All other authors have reported that they have no competing interests to report., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)- Published
- 2022
- Full Text
- View/download PDF
46. Author Correction: Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells.
- Author
-
Khatri B, Tessneer KL, Rasmussen A, Aghakhanian F, Reksten TR, Adler A, Alevizos I, Anaya JM, Aqrawi LA, Baecklund E, Brun JG, Bucher SM, Eloranta ML, Engelke F, Forsblad-d'Elia H, Glenn SB, Hammenfors D, Imgenberg-Kreuz J, Jensen JL, Johnsen SJA, Jonsson MV, Kvarnström M, Kelly JA, Li H, Mandl T, Martín J, Nocturne G, Norheim KB, Palm Ø, Skarstein K, Stolarczyk AM, Taylor KE, Teruel M, Theander E, Venuturupalli S, Wallace DJ, Grundahl KM, Hefner KS, Radfar L, Lewis DM, Stone DU, Kaufman CE, Brennan MT, Guthridge JM, James JA, Scofield RH, Gaffney PM, Criswell LA, Jonsson R, Eriksson P, Bowman SJ, Omdal R, Rönnblom L, Warner B, Rischmueller M, Witte T, Farris AD, Mariette X, Alarcon-Riquelme ME, Shiboski CH, Wahren-Herlenius M, Ng WF, Sivils KL, Adrianto I, Nordmark G, and Lessard CJ
- Published
- 2022
- Full Text
- View/download PDF
47. Recent advances in hidradenitis suppurativa: Role of race, genetics, and immunology.
- Author
-
Vellaichamy G, Amin AT, Dimitrion P, Hamzavi Z, Zhou L, Adrianto I, and Mi QS
- Abstract
Hidradenitis suppurativa (HS) is a multifactorial chronic skin disease characterized by inflammation around the hair follicles commonly affecting intertriginous areas. The underlying pathogenesis of HS and its molecular mechanisms are largely understudied. Genetic studies in families have identified variants within the γ-secretase complex associated with HS; however, no definitive genotype-phenotype correlations have been made. The lack of knowledge regarding the intersection of genetics, immunology and environmental risk factors is a major obstacle to improving treatment for patients with HS. This article provides an overview of the role of race, genetics, and immunology in HS to provide insight into the multiple factors influencing the pathophysiology of HS., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Vellaichamy, Amin, Dimitrion, Hamzavi, Zhou, Adrianto and Mi.)
- Published
- 2022
- Full Text
- View/download PDF
48. A stacked regression ensemble approach for the quantitative determination of biomass feedstock compositions using near infrared spectroscopy.
- Author
-
Dumancas G and Adrianto I
- Subjects
- Biomass, Least-Squares Analysis, Plant Extracts, Lignin, Spectroscopy, Near-Infrared methods
- Abstract
Rapid, robust, and accurate biomass compositional analyses are required in the bioenergy industry to accurately determine the chemical composition of biomass feedstocks. A stacked regression ensemble approach using near infrared spectroscopic method was developed for the quantitative determination of glucan, xylan, lignin, ash, and extract in biomass feedstocks. A comprehensive comparison of the performance of various machine learning techniques including support vector regression (linear and radial), least absolute shrinkage and selection operator (LASSO), ridge regression, elastic net, partial least squares, random forests, recursive partitioning and regression trees, gradient boosting, and gaussian process regression was assessed in the training set data (n = 188). The predictive performance of the aforementioned machine learning approaches was then compared with stacked regression, an ensemble learning algorithm which collates the performance of the abovementioned machine learning regression techniques. Results show that the stacked regression primarily outperformed other machine learning techniques (Root mean square error of prediction (RMSEP)
average =1.660%wt,R2 =0.907) across all five constituents in the validation set data (n = 81). Further results also show that the RMSEP of the stacked ensemble technique is significantly different than that of the partial least squares (PLS) approach in predicting glucan, ash, lignin, and extract components in biomass samples. The stacked ensemble learning approach offers an alternative method for a more accurate prediction of biomass compositions than the traditional PLS technique., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Elsevier B.V. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
49. Single-cell analysis reveals differences among iNKT cells colonizing peripheral organs and identifies Klf2 as a key gene for iNKT emigration.
- Author
-
Wang J, Loveless I, Adrianto I, Liu T, Subedi K, Wu X, Hossain MM, Sebzda E, Zhou L, and Mi QS
- Abstract
Invariant natural killer T cell (iNKT) subsets are differentially distributed in various immune organs. However, it remains unclear whether iNKT cells exhibit phenotypical and functional differences in different peripheral organs and how thymic iNKT cells emigrate to peripheral organs. Here, we used single-cell RNA-seq to map iNKT cells from peripheral organs. iNKT1 cells from liver, spleen, and lymph node appear to have distinct phenotypic profiles and functional capabilities. However, iNKT17 transcriptomes were comparable across peripheral organs. In addition, by integrating data with a thymic iNKT cell study, we uncovered a transient population of recent thymic emigrants, a cluster of peripheral iNKT cells with high expression of transcription factor Kruppel-like factor 2 (Klf2). Deletion of Klf2 led to a severe impairment of iNKT differentiation and migration. Our study revealed that iNKT subsets are uniquely distributed in peripheral organs with some inter-local tissue variation, especially for iNKT1 cell, and identified Klf2 as a rheostat for iNKT cell migration and differentiation., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
50. Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells.
- Author
-
Khatri B, Tessneer KL, Rasmussen A, Aghakhanian F, Reksten TR, Adler A, Alevizos I, Anaya JM, Aqrawi LA, Baecklund E, Brun JG, Bucher SM, Eloranta ML, Engelke F, Forsblad-d'Elia H, Glenn SB, Hammenfors D, Imgenberg-Kreuz J, Jensen JL, Johnsen SJA, Jonsson MV, Kvarnström M, Kelly JA, Li H, Mandl T, Martín J, Nocturne G, Norheim KB, Palm Ø, Skarstein K, Stolarczyk AM, Taylor KE, Teruel M, Theander E, Venuturupalli S, Wallace DJ, Grundahl KM, Hefner KS, Radfar L, Lewis DM, Stone DU, Kaufman CE, Brennan MT, Guthridge JM, James JA, Scofield RH, Gaffney PM, Criswell LA, Jonsson R, Eriksson P, Bowman SJ, Omdal R, Rönnblom L, Warner B, Rischmueller M, Witte T, Farris AD, Mariette X, Alarcon-Riquelme ME, Shiboski CH, Wahren-Herlenius M, Ng WF, Sivils KL, Adrianto I, Nordmark G, and Lessard CJ
- Subjects
- Genetic Predisposition to Disease, Humans, Polymorphism, Single Nucleotide, Genome-Wide Association Study, Sjogren's Syndrome genetics
- Abstract
Sjögren's disease is a complex autoimmune disease with twelve established susceptibility loci. This genome-wide association study (GWAS) identifies ten novel genome-wide significant (GWS) regions in Sjögren's cases of European ancestry: CD247, NAB1, PTTG1-MIR146A, PRDM1-ATG5, TNFAIP3, XKR6, MAPT-CRHR1, RPTOR-CHMP6-BAIAP6, TYK2, SYNGR1. Polygenic risk scores yield predictability (AUROC = 0.71) and relative risk of 12.08. Interrogation of bioinformatics databases refine the associations, define local regulatory networks of GWS SNPs from the 95% credible set, and expand the implicated gene list to >40. Many GWS SNPs are eQTLs for genes within topologically associated domains in immune cells and/or eQTLs in the main target tissue, salivary glands., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.